BARCLAYS PLC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 147 filers reported holding IMMUNITYBIO INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$75
-55.4%
44,373
-26.6%
0.00%
Q2 2023$168
+124.0%
60,469
+46.5%
0.00%
Q1 2023$75
-94.2%
41,288
-83.9%
0.00%
-100.0%
Q4 2022$1,300
-99.9%
256,365
+1.3%
0.00%0.0%
Q3 2022$1,257,000
+3042.5%
253,030
+2229.3%
0.00%
Q2 2022$40,000
-39.4%
10,863
-6.7%
0.00%
Q1 2022$66,00011,6410.00%
Other shareholders
IMMUNITYBIO INC shareholders Q1 2023
NameSharesValueWeighting ↓
HARBOURVEST PARTNERS LLC 335,709$933,2710.26%
ALLEN HOLDING INC /NY 687,571$1,911,4470.26%
Clearwater Capital Advisors, LLC 394,599$1,096,9860.13%
SHEETS SMITH WEALTH MANAGEMENT 269,129$748,1790.11%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$268,0840.10%
WEALTH EFFECTS LLC 71,000$197,3800.09%
Virtus ETF Advisers LLC 37,888$105,3290.06%
DARK FOREST CAPITAL MANAGEMENT LP 203,659$566,1720.05%
Bell & Brown Wealth Advisors, LLC 20,100$55,8780.03%
FISHMAN JAY A LTD/MI 162,000$450,3600.03%
View complete list of IMMUNITYBIO INC shareholders